Novo Nordisk
Copenhagen, DK · 2 known investors
Novo Nordisk is a pharmaceutical company that develops and markets treatments for diabetes, hemophilia, weight management, and other chronic diseases through innovative drug therapies.
Investors · 2
Acquisitions · 3
Early investors' stakes continue via these dealsForma Therapeutics
Clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare hematologic diseases and cancers, acquired by Novo Nordisk in 2022.
Inversago
Portfolio company acquired by Novo Nordisk for $1.1B USD.
KBP
Hypertension company acquired by Novo Nordisk.